Q2 2025 has demonstrated the pharmaceutical industry’s continued momentum in developing transformative therapies across ...

The second healthcare sector IPCEI – approving up to €403 million of State aid by five Member States, including France, ...

Replimune Group, Inc – a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies – ...

Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the ...

As usual, the one-two punch of ASCO and BIO set us a bit behind, but never fear – your June hires round-up is here at least ...